+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Arthritis Treatment Market 2025-2029- Product Image
Canine Arthritis Treatment Market 2025-2029- Product Image
New

Canine Arthritis Treatment Market 2025-2029

  • PDF Icon

    Report

  • 215 Pages
  • May 2025
  • Region: Global
  • TechNavio
  • ID: 6091450
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The canine arthritis treatment market is forecasted to grow by USD 826 million during 2024-2029, accelerating at a CAGR of 6.3% during the forecast period. The report on the canine arthritis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of canine arthritis, increasing pet ownership and the humanization of pets, and rising disposable income.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The canine arthritis treatment market is segmented as below:

By Product

  • NSAIDs
  • Opioids
  • Others

By Route Of Administration

  • Oral
  • Injectables
  • Intra-articular injection

By Distribution Channel

  • Offline
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancement in treatment options for canine arthritis as one of the prime reasons driving the canine arthritis treatment market growth during the next few years. Also, increasing focus on awareness campaigns and integration of technology in monitoring and treatment of canine arthritis will lead to sizable demand in the market.

The report on the canine arthritis treatment market covers the following areas:

  • Canine Arthritis Treatment Market sizing
  • Canine Arthritis Treatment Market forecast
  • Canine Arthritis Treatment Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading canine arthritis treatment market vendors that include American Regent Animal Health, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Compana Pet Brands LLC, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., NexGen Pharmaceuticals, Norbrook Laboratories Ltd., Nutramax Laboratories Inc., Thorne Vet., Vetoquinol SA, VetStem Biopharma, Virbac Group, and Zoetis Inc. Also, the canine arthritis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Canine Arthritis Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Canine Arthritis Treatment Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact Analysis of U.S. Tariff War on Global Canine Arthritis Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 NSAIDs - Market size and forecast 2024-2029
Chart on NSAIDs - Market size and forecast 2024-2029 ($ million)
Data Table on NSAIDs - Market size and forecast 2024-2029 ($ million)
Chart on NSAIDs - Year-over-year growth 2024-2029 (%)
Data Table on NSAIDs - Year-over-year growth 2024-2029 (%)
8.4 Opioids - Market size and forecast 2024-2029
Chart on Opioids - Market size and forecast 2024-2029 ($ million)
Data Table on Opioids - Market size and forecast 2024-2029 ($ million)
Chart on Opioids - Year-over-year growth 2024-2029 (%)
Data Table on Opioids - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
9.5 Intra-articular injection - Market size and forecast 2024-2029
Chart on Intra-articular injection - Market size and forecast 2024-2029 ($ million)
Data Table on Intra-articular injection - Market size and forecast 2024-2029 ($ million)
Chart on Intra-articular injection - Year-over-year growth 2024-2029 (%)
Data Table on Intra-articular injection - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Distribution Channel
10.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
10.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
10.3 Offline - Market size and forecast 2024-2029
Chart on Offline - Market size and forecast 2024-2029 ($ million)
Data Table on Offline - Market size and forecast 2024-2029 ($ million)
Chart on Offline - Year-over-year growth 2024-2029 (%)
Data Table on Offline - Year-over-year growth 2024-2029 (%)
10.4 Online - Market size and forecast 2024-2029
Chart on Online - Market size and forecast 2024-2029 ($ million)
Data Table on Online - Market size and forecast 2024-2029 ($ million)
Chart on Online - Year-over-year growth 2024-2029 (%)
Data Table on Online - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.13 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 Australia - Market size and forecast 2024-2029
Chart on Australia - Market size and forecast 2024-2029 ($ million)
Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Chart on Australia - Year-over-year growth 2024-2029 (%)
Data Table on Australia - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 American Regent Animal Health
American Regent Animal Health - Overview
American Regent Animal Health - Product / Service
American Regent Animal Health - Key offerings
SWOT
15.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
15.6 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.7 Ceva Sante Animale
Ceva Sante Animale - Overview
Ceva Sante Animale - Product / Service
Ceva Sante Animale - Key offerings
SWOT
15.8 Compana Pet Brands LLC
Compana Pet Brands LLC - Overview
Compana Pet Brands LLC - Product / Service
Compana Pet Brands LLC - Key offerings
SWOT
15.9 Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc - Overview
Dechra Pharmaceuticals Plc - Business segments
Dechra Pharmaceuticals Plc - Key offerings
Dechra Pharmaceuticals Plc - Segment focus
SWOT
15.10 Elanco Animal Health Inc.
Elanco Animal Health Inc. - Overview
Elanco Animal Health Inc. - Product / Service
Elanco Animal Health Inc. - Key offerings
SWOT
15.11 Jurox Pty Ltd.
Jurox Pty Ltd. - Overview
Jurox Pty Ltd. - Product / Service
Jurox Pty Ltd. - Key offerings
SWOT
15.12 NexGen Pharmaceuticals
NexGen Pharmaceuticals - Overview
NexGen Pharmaceuticals - Product / Service
NexGen Pharmaceuticals - Key offerings
SWOT
15.13 Norbrook Laboratories Ltd.
Norbrook Laboratories Ltd. - Overview
Norbrook Laboratories Ltd. - Product / Service
Norbrook Laboratories Ltd. - Key offerings
SWOT
15.14 Nutramax Laboratories Inc.
Nutramax Laboratories Inc. - Overview
Nutramax Laboratories Inc. - Product / Service
Nutramax Laboratories Inc. - Key offerings
SWOT
15.15 Vetoquinol SA
Vetoquinol SA - Overview
Vetoquinol SA - Business segments
Vetoquinol SA - Key offerings
Vetoquinol SA - Segment focus
SWOT
15.16 VetStem Biopharma
VetStem Biopharma - Overview
VetStem Biopharma - Product / Service
VetStem Biopharma - Key offerings
SWOT
15.17 Virbac Group
Virbac Group - Overview
Virbac Group - Business segments
Virbac Group - Key offerings
Virbac Group - Segment focus
SWOT
15.18 Zoetis Inc.
Zoetis Inc. - Overview
Zoetis Inc. - Business segments
Zoetis Inc. - Key news
Zoetis Inc. - Key offerings
Zoetis Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Canine Arthritis Treatment Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Product - Market share 2024-2029 (%)
Exhibits 39: Data Table on Product - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Product
Exhibits 41: Data Table on Comparison by Product
Exhibits 42: Chart on NSAIDs - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on NSAIDs - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on NSAIDs - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on NSAIDs - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Opioids - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Opioids - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Opioids - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Opioids - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Product ($ million)
Exhibits 55: Data Table on Market opportunity by Product ($ million)
Exhibits 56: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 57: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Route of Administration
Exhibits 59: Data Table on Comparison by Route of Administration
Exhibits 60: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Intra-articular injection - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Intra-articular injection - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Intra-articular injection - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Intra-articular injection - Year-over-year growth 2024-2029 (%)
Exhibits 72: Market opportunity by Route of Administration ($ million)
Exhibits 73: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 74: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 75: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 76: Chart on Comparison by Distribution Channel
Exhibits 77: Data Table on Comparison by Distribution Channel
Exhibits 78: Chart on Offline - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Offline - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Offline - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Offline - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Online - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Online - Year-over-year growth 2024-2029 (%)
Exhibits 86: Market opportunity by Distribution Channel ($ million)
Exhibits 87: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 91: Chart on Geographic comparison
Exhibits 92: Data Table on Geographic comparison
Exhibits 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 149: Market opportunity By Geographical Landscape ($ million)
Exhibits 150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 151: Impact of drivers and challenges in 2024 and 2029
Exhibits 152: Overview on criticality of inputs and factors of differentiation
Exhibits 153: Overview on factors of disruption
Exhibits 154: Impact of key risks on business
Exhibits 155: Companies covered
Exhibits 156: Company ranking index
Exhibits 157: Matrix on companies position and classification
Exhibits 158: American Regent Animal Health - Overview
Exhibits 159: American Regent Animal Health - Product / Service
Exhibits 160: American Regent Animal Health - Key offerings
Exhibits 161: SWOT
Exhibits 162: Bayer AG - Overview
Exhibits 163: Bayer AG - Business segments
Exhibits 164: Bayer AG - Key news
Exhibits 165: Bayer AG - Key offerings
Exhibits 166: Bayer AG - Segment focus
Exhibits 167: SWOT
Exhibits 168: Boehringer Ingelheim International GmbH - Overview
Exhibits 169: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 170: Boehringer Ingelheim International GmbH - Key news
Exhibits 171: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 172: SWOT
Exhibits 173: Ceva Sante Animale - Overview
Exhibits 174: Ceva Sante Animale - Product / Service
Exhibits 175: Ceva Sante Animale - Key offerings
Exhibits 176: SWOT
Exhibits 177: Compana Pet Brands LLC - Overview
Exhibits 178: Compana Pet Brands LLC - Product / Service
Exhibits 179: Compana Pet Brands LLC - Key offerings
Exhibits 180: SWOT
Exhibits 181: Dechra Pharmaceuticals Plc - Overview
Exhibits 182: Dechra Pharmaceuticals Plc - Business segments
Exhibits 183: Dechra Pharmaceuticals Plc - Key offerings
Exhibits 184: Dechra Pharmaceuticals Plc - Segment focus
Exhibits 185: SWOT
Exhibits 186: Elanco Animal Health Inc. - Overview
Exhibits 187: Elanco Animal Health Inc. - Product / Service
Exhibits 188: Elanco Animal Health Inc. - Key offerings
Exhibits 189: SWOT
Exhibits 190: Jurox Pty Ltd. - Overview
Exhibits 191: Jurox Pty Ltd. - Product / Service
Exhibits 192: Jurox Pty Ltd. - Key offerings
Exhibits 193: SWOT
Exhibits 194: NexGen Pharmaceuticals - Overview
Exhibits 195: NexGen Pharmaceuticals - Product / Service
Exhibits 196: NexGen Pharmaceuticals - Key offerings
Exhibits 197: SWOT
Exhibits 198: Norbrook Laboratories Ltd. - Overview
Exhibits 199: Norbrook Laboratories Ltd. - Product / Service
Exhibits 200: Norbrook Laboratories Ltd. - Key offerings
Exhibits 201: SWOT
Exhibits 202: Nutramax Laboratories Inc. - Overview
Exhibits 203: Nutramax Laboratories Inc. - Product / Service
Exhibits 204: Nutramax Laboratories Inc. - Key offerings
Exhibits 205: SWOT
Exhibits 206: Vetoquinol SA - Overview
Exhibits 207: Vetoquinol SA - Business segments
Exhibits 208: Vetoquinol SA - Key offerings
Exhibits 209: Vetoquinol SA - Segment focus
Exhibits 210: SWOT
Exhibits 211: VetStem Biopharma - Overview
Exhibits 212: VetStem Biopharma - Product / Service
Exhibits 213: VetStem Biopharma - Key offerings
Exhibits 214: SWOT
Exhibits 215: Virbac Group - Overview
Exhibits 216: Virbac Group - Business segments

Executive Summary

The following companies are recognized as the key players in the global canine arthritis treatment market: American Regent Animal Health, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Compana Pet Brands LLC, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., NexGen Pharmaceuticals, Norbrook Laboratories Ltd., Nutramax Laboratories Inc., Thorne Vet., Vetoquinol SA, VetStem Biopharma, Virbac Group, and Zoetis Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancement in treatment options for canine arthritis."

According to the report, one of the major drivers for this market is the rising prevalence of canine arthritis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • American Regent Animal Health
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Compana Pet Brands LLC
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Jurox Pty Ltd.
  • NexGen Pharmaceuticals
  • Norbrook Laboratories Ltd.
  • Nutramax Laboratories Inc.
  • Thorne Vet.
  • Vetoquinol SA
  • VetStem Biopharma
  • Virbac Group
  • Zoetis Inc.

Related Topics

Related Reports

Canine Arthritis Treatment Market Report 2025 - Product Image

Canine Arthritis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bovine Treatment System Market 2024-2028 - Product Image

Bovine Treatment System Market 2024-2028

  • Report
  • 161 Pages
  • Global
From
Bovine Mastitis Treatment System Market 2024-2028 - Product Image

Bovine Mastitis Treatment System Market 2024-2028

  • Report
  • 159 Pages
  • Global
From
Veterinary Vaccines Market 2025-2029 - Product Image

Veterinary Vaccines Market 2025-2029

  • Report
  • 231 Pages
  • Global
From
U.S. Pet Medication Market - Focused Insights 2024-2029 - Product Image

U.S. Pet Medication Market - Focused Insights 2024-2029

  • Report
  • 86 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.